Evommune, Inc. (EVMN) — Institutional Holders, Q2 2026 (page 2)
105 institutional investment managers reported a EVMN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $462.4M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 105. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EVMN 13F holders ranked 101–105 of 105
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 101 | GAMMA Investing#101 · 24 sh | 24 | $319.00 | — | New |
| 102 | FIFTH THIRD BANCORP#102 · 21 sh | 21 | $273.00 | 0.00% | 0.0% |
| 103 | Allworth Financial#103 · 2 sh | 2 | $27.00 | 0.00% | New |
| 104 | SRS Capital Advisors#104 · 1 sh | 1 | $13.00 | 0.00% | New |
| 105 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#105 · 11,660 sh | 11,660 | — | — | +1942.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.